BPI Theater Insider Interview, Sigma Mostafa, KBI Biopharma
By
BPI Contributor
12d agoen
Source
bioprocessintl.comBPI Theater Insider Interview, Sigma Mostafa, KBI Biopharmabioprocessintl.comKBI’s chief scientific officer reflects on the company’s 30 years of working with drug developers to translate key discoveries into viable medicines.
You might also wanna read
Basel Area Business & Innovation partners with Korean biopharma firms Roche Korea, KHIDI, and KIBO
Basel Area Business & Innovation has announced a new collaboration with Korean biopharma companies including Roche Korea, the Korea Health I
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
Bio Usawa appoints former Pfizer chief medical officer Dr. Aida Habtezion to board of directors
Bio Usawa, a biotechnology company focused on expanding access to high-quality biologic medicines in Africa and other underserved regions, h

ABL Bio doubles down on self-sustainable growth beyond licensing deals
The Korea Herald·23h ago
5 Takeaways from Paige Pidano Paridon’s Testimony on Payments
Bank Policy Institute·13d ago

Focus, bold bets, and a bit of fun: How a pharma chief is going for growth
IMD·23h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.